Osteopontin is critical to determine symptom severity of influenza through the regulation of NK cell population

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 274-279

  Sato, Kayoko ^a,b   Iwai, Atsushi ^a   Nakayama, Yosuke ^a   Morimoto, Junko ^a   Takada, Ayato ^a   Maruyama, Mitsuo ^c   Kida, Hiroshi ^a,d,e   Uede, Toshimitsu ^a   Miyazaki, Tadaaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e OIE Reference Laboratory for Highly Pathogenic Avian Influenza   (Japan)

Author keywords

Influenza A virus; Innate immunity; Natural killer cell; Osteopontin

Indexed keywords

OSTEOPONTIN; RECOMBINANT OSTEOPONTIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNE RESPONSE; INFLUENZA A; INNATE IMMUNITY; KNOCKOUT MOUSE; LUNG; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN CELL; TRANSGENIC MOUSE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; WILD TYPE;

ANIMALS; INFLUENZA A VIRUS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE INFECTIONS; OSTEOPONTIN; PNEUMONIA, VIRAL; SEVERITY OF ILLNESS INDEX;

INFLUENZA A VIRUS; MUS; MUS MUSCULUS;

EID: 84855760130     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.100     Document Type: Article

References (35)

1. Van Reeth K., Nauwynck H., Pensaert M. Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans?. J. Infect. Dis. 1998, 177:1076-1079.
2. Julkunen I., Sareneva T., Pirhonen J., Ronni T., Melen K., Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 2001, 12:171-180.
3. Kaiser L., Fritz R.S., Straus S.E., Gubareva L., Hayden F.G. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J. Med. Virol. 2001, 64:262-268.
4. Mok K.P., Wong C.H., Cheung C.Y., Chan M.C., Lee S.M., Nicholls J.M., Guan Y., Peiris J.S. Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation. J. Infect. Dis. 2009, 200:1104-1112.
5. Kaufmann A., Salentin R., Meyer R.G., Bussfeld D., Pauligk C., Fesq H., Hofmann P., Nain M., Gemsa D., Sprenger H. Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology 2001, 204:603-613.
6. Seo S.H., Webster R.G. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J. Virol. 2002, 76:1071-1076.
7. Matikainen S., Siren J., Tissari J., Veckman V., Pirhonen J., Severa M., Sun Q., Lin R., Meri S., Uze G., Hiscott J., Julkunen I. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 2006, 80:3515-3522.
8. I.D. Weiss, O. Wald, H. Wald, K. Beider, M. Abraham, E. Galun, A. Nagler, A. Peled, IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner, J. Interferon Cytokine Res. 30 439-449.
9. Salomon R., Hoffmann E., Webster R.G. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl. Acad. Sci. USA 2007, 104:12479-12481.
10. Prince C.W., Oosawa T., Butler W.T., Tomana M., Bhown A.S., Bhown M., Schrohenloher R.E. Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J. Biol. Chem. 1987, 262:2900-2907.
11. Giachelli C.M., Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000, 19:615-622.
12. Scatena M., Liaw L., Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2302-2309.
13. Uede T., Katagiri Y., Iizuka J., Murakami M. Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein?. Microbiol. Immunol. 1997, 41:641-648.
14. Wang K.X., Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008, 19:333-345.
15. Morimoto J., Kon S., Matsui Y., Uede T. Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr. Drug Targets 2010, 11:494-505.
16. Yumoto K., Ishijima M., Rittling S.R., Tsuji K., Tsuchiya Y., Kon S., Nifuji A., Uede T., Denhardt D.T., Noda M. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. USA 2002, 99:4556-4561.
17. Yamamoto N., Sakai F., Kon S., Morimoto J., Kimura C., Yamazaki H., Okazaki I., Seki N., Fujii T., Uede T. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 2003, 112:181-188.
18. Diao H., Kon S., Iwabuchi K., Kimura C., Morimoto J., Ito D., Segawa T., Maeda M., Hamuro J., Nakayama T., Taniguchi M., Yagita H., Van Kaer L., Onoe K., Denhardt D., Rittling S., Uede T. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004, 21:539-550.
19. Saito Y., Kon S., Fujiwara Y., Nakayama Y., Kurotaki D., Fukuda N., Kimura C., Kanayama M., Ito K., Diao H., Matsui Y., Komatsu Y., Ohtsuka E., Uede T. Osteopontin small interfering RNA protects mice from fulminant hepatitis. Hum. Gene Ther. 2007, 18:1205-1214.
20. Yoshitake H., Rittling S.R., Denhardt D.T., Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc. Natl. Acad. Sci. USA 1999, 96:8156-8160.
21. Rittling S.R., Denhardt D.T. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp. Nephrol. 1999, 7:103-113.
22. Iizuka J., Katagiri Y., Tada N., Murakami M., Ikeda T., Sato M., Hirokawa K., Okada S., Hatano M., Tokuhisa T., Uede T. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Lab. Invest. 1998, 78:1523-1533.
23. Takada A., Matsushita S., Ninomiya A., Kawaoka Y., Kida H. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003, 21:3212-3218.
24. Carlson I., Tognazzi K., Manseau E.J., Dvorak H.F., Brown L.F. Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab. Invest. 1997, 77:103-108.
25. Yokosaki Y., Matsuura N., Sasaki T., Murakami I., Schneider H., Higashiyama S., Saitoh Y., Yamakido M., Taooka Y., Sheppard D. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 1999, 274:36328-36334.
26. Kees U., Krammer P.H. Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants. J. Exp. Med. 1984, 159:365-377.
27. Perrone L.A., Plowden J.K., Garcia-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008, 4:e1000115.
28. Tate M.D., Pickett D.L., van Rooijen N., Brooks A.G., Reading P.C. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 2010, 84:7569-7580.
29. Kos F.J., Engleman E.G. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell. Immunol. 1996, 173:1-6.
30. Chung J.W., Kim M.S., Piao Z.H., Jeong M., Yoon S.R., Shin N., Kim S.Y., Hwang E.S., Yang Y., Lee Y.H., Kim Y.S., Choi I. Osteopontin promotes the development of natural killer cells from hematopoietic stem cells. Stem cells 2008, 26:2114-2123.
31. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., Hatta Y., Kim J.H., Halfmann P., Hatta M., Feldmann F., Alimonti J.B., Fernando L., Li Y., Katze M.G., Feldmann H., Kawaoka Y. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445:319-323.
32. Cilloniz C., Shinya K., Peng X., Korth M.J., Proll S.C., Aicher L.D., Carter V.S., Chang J.H., Kobasa D., Feldmann F., Strong J.E., Feldmann H., Kawaoka Y., Katze M.G. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 2009, 5:e1000604.
33. Koguchi Y., Kawakami K., Kon S., Segawa T., Maeda M., Uede T., Saito A. Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells. Infect. Immun. 2002, 70:1042-1048.
34. Koguchi Y., Kawakami K., Uezu K., Fukushima K., Kon S., Maeda M., Nakamoto A., Owan I., Kuba M., Kudeken N., Azuma M., Yara S., Shinzato T., Higa F., Tateyama M., Kadota J., Mukae H., Kohno S., Uede T., Saito A. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am. J. Respir. Crit. Care Med. 2003, 167:1355-1359.
35. Abel B., Freigang S., Bachmann M.F., Boschert U., Kopf M. Osteopontin is not required for the development of Th1 responses and viral immunity. J. Immunol. 2005, 175:6006-6013.